The Surrey Cardiovascular Clinic Podcast
av D E Leatham
The Galleri Blood Test: What It Can and Cannot Tell You
Om denne podkasten
The Surrey Cardiovascular Clinic Podcast features AI-generated discussions based on clinical articles published by The Surrey Cardiovascular Clinic (SCVC).
Each episode explores contemporary issues in cardiology and cardiometabolic health, translating detailed blog content into an accessible audio format. Topics include cardiovascular risk, metabolic health, prevention strategies and structured clinical escalation.
The series is authored by Dr Edward Leatham, Consultant Cardiologist, and is intended for GPs, junior doctors and patients. It may also be of interest to healthcare professionals and others involved in the wider cardiovascular health sector.
Disclosure
Dr Leatham is Director and Founder of the Surrey Cardiovascular Clinic and, since 2019, Co-Founder and Managing Director of HeartScanDirect (https://www.heartscandirect.com/), one of the UK’s leading cardiac CT providers specialising in AI-processed scans and among the few cardiologist-led CT services in the country. Dr Leatham’s own private medical practice is based at the Surrey cardiovascular clinic and therefore has a major financial interest in the Surrey Cardiovascular clinic, the Virtual Cath Lab and Vat-Trap.com. He has no financial relationship with any pharma company or product.
A full disclosure is available at https://www.vat-trap.com/disclosures.
Episoder
- The Galleri Blood Test: What It Can and Cannot Tell You · 6 min · Episode 19Galleri rarely raises a false alarm and often points to the right organ, but it misses most cancers overall, and the first large randomised trial did not show fewer advanced…
- The Smartphone That Could Save a Family Member's Life: AliveCor and the Case for Home AF Screening · 2 min · Episode 18Atrial fibrillation is a leading hidden cause of stroke, often missed because it comes and goes without warning. A small device called AliveCor KardiaMobile turns any smartphone…
- Beyond the Heart: Should We Be Screening for Cancer Before Symptoms Develop? · 19 min · Episode 17As cardiovascular medicine becomes better at predicting and preventing heart disease, cancer has emerged as the greater threat to long-term health. This article explores the…
- Diet, Cholesterol and the Question No One Can Answer in Advance · 20 min · Episode 16Deciding whether a statin is right for you depends on two things: your measurable cardiovascular risk and how much your cholesterol is actually influenced by diet. Both questions…
- Ask the Evidence: How to Use AI to Get Real Answers From Our Cardiovascular Articles · 21 min · Episode 15A new tool on every SCVC article lets you interrogate the evidence behind our advice using your own AI assistant — here is how it works and why it matters…
- Why a cardiovascular clinic started running men’s health clinics · 21 min · Episode 14Men attending a heart clinic rarely come in with just one concern. Erectile dysfunction, prostate health and unexplained weight gain share biological pathways with cardiovascular…
- Metabolic Health Assessment (MHA) — Early Detection of Insulin Resistance Beyond HbA1c · 6 min · Episode 13Insulin resistance often develops silently for years before diabetes or heart disease appears. Discover how modern metabolic assessment, including body composition, visceral fat…
- https://www.scvc.co.uk/cardiovascular-prevention/cardiologist-body-recomposition/ · 24 min · Episode 12Body recomposition focuses on reducing visceral fat while preserving muscle mass, offering superior cardiovascular protection compared to traditional weight loss. This approach…
- TOE Before Cardioversion: Why Cardiologists Check for Hidden Clots · 20 min · Episode 11Transoesophageal echocardiography before atrial fibrillation cardioversion prevents stroke by detecting hidden left atrial appendage clots. The greatest risk comes from atrial…
- A Single Episode of Atrial Fibrillation with a CHA₂DS₂-VASc Score ≥2: Do You Need Anticoagulants for Life? · 21 min · Episode 10A single episode of atrial fibrillation in patients with a CHA₂DS₂-VASc score ≥2 often leads to a recommendation for lifelong anticoagulation. But is this always necessary? This…
- Atrial Fibrillation or Flutter with a Low CHA₂DS₂-VASc Score: Why Cardioversion Still Carries Stroke Risk · 19 min · Episode 9Patients with a low CHA₂DS₂-VASc score are often considered low risk for stroke. However, around cardioversion, this changes. Atrial paresis following restoration of sinus rhythm…
- LDL Cholesterol Reduction: Absolute Beats Relative? It’s “And,” Not “Or” · 18 min · Episode 8Modern lipid management requires both substantial percentage LDL reduction and achieving low absolute LDL levels. Relative reduction reflects treatment intensity, while absolute…
- Targets for LDL-C, ApoB and Small Dense LDL · 18 min · Episode 7LDL-C alone may miss important cardiovascular risk. This article explains why ApoB and small dense LDL often better reflect atherosclerotic burden, especially in metabolic…
- The Role of Gain of Function Mutations in Heart Disease · 18 min · Episode 5Gain-of-function mutations in PCSK9 increase LDL cholesterol by accelerating LDL receptor degradation, helping explain inherited cardiovascular risk. Unlike evolutionary…
- Cardiometabolic Risk in 2026: From Self-Management to Structured Escalation · 17 min · Episode 4Cardiometabolic risk develops gradually through visceral fat accumulation, insulin resistance and rising blood pressure. A structured escalation model — from supported…
- THE CHOICE: How Cardiologists Operate GLP-1 Mimetics in Practice · 16 min · Episode 3Semaglutide’s cardiovascular benefits extend beyond weight loss — it powerfully reduces visceral adipose tissue (VAT), the internal fat that drives inflammation, insulin…
- The 8-Month Metabolic Reset: A New Approach to Reversing Visceral Fat, Improving Blood Pressure and Blood Glucose · 22 min · Episode 6As we age — particularly if we have inherited genes that predispose us to metabolic disarray that accompanies modern diet and lifestyles, we start to gain weight as visceral fat…
- Some hypothyroid patients with heart disease are prescribed T4 that doesn't convert to T3 · 12 min · Episode 2Hypothyroidism is a very common medical condition. Most patients symptoms improve with standard thyroxine treatment, however some do not. There are some genetic variations that…
- BP Targets: a personalised approach · 8 min · Episode 1This podcast is a discussion around Guidance Document for GPs on Blood Pressure Management: Timeline of Events - where significant events and research in the evolution of blood…








